PMVP

PMV Pharmaceuticals Inc

$16.64

chg

-0.41 (-2.40%)

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

8.99

52 wk hi

35.75

Cash

$283.0M

Burn Rate (Qtr)

$18.0M

Mkt Cap

$758.4m

Avg Volume

595,398

*cash/burn updated:

Q1 '22

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information.

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Loading Catalysts...

search in progress

Pipeline powered by

PMVP

BPIQ_Logo_RGB-01.jpg

Company Profile

At PMV, we believe that by specifically targeting each mutant p53 we can fundamentally disrupt the course of cancer. Our research and development efforts are dedicated to selectively targeting mutant p53, providing unique therapies for any patient whose tumor harbors these gene mutations.

Recent Posts

See what the community is saying - click to see full post.